A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : MIC90s

Search Conditions:
Search Keyword : MIC90s
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: MIC90s
Appearance Frequency: 58 time(s)
Long forms: 15

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
MICs at which 90% of the isolates are inhibited
(27 times)
Anti-Bacterial Agents
(27 times)
PRSP (2 times)
LPL (1 time)
LPTA (1 time)
1995 In vitro activity of a new fluoroquinolone, CP-99,219, against strains of Neisseria gonorrhoeae.
MICs for 90% of strains tested
(14 times)
Anti-Bacterial Agents
(13 times)
MRSA (1 time)
1989 Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
MICs for 90% of the strains
(3 times)
Anti-Bacterial Agents
(3 times)
--- 1987 Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721.
MICs for 90
(2 times)
Anti-Bacterial Agents
(2 times)
--- 1988 Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.
MICs of FK-037 for 90% of the strains tested
(2 times)
Anti-Bacterial Agents
(2 times)
--- 1992 In vitro antibacterial activity of Q-35, a new fluoroquinolone.
MICs at which 90% of strains tested
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1995 In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
MICs for 90% of the organisms
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1991 Activity of new quinolones against ciprofloxacin-resistant staphylococci.
MICs of E-4868 for 90% of the isolates tested
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1993 In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.
MICs of FK037 for 90% of the clinical isolates tested
(1 time)
Drug Therapy
(1 time)
H-MRSA (1 time)
L-MRSA (1 time)
1994 In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
10  MICs of the new drug for 90% of strains tested
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1990 Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
11  MICs that inhibited 90% strains tested
(1 time)
Anti-Bacterial Agents
(1 time)
--- 1995 In vitro activity of the semisynthetic glycopeptide amide MDL 63,246.
12  Minimal inhibitory concentrations inhibiting 90% of strains
(1 time)
Ophthalmology
(1 time)
--- 1993 Antimicrobial activity and in vitro corneal epithelial toxicity of antimicrobial agents for gram-positive corneal pathogens.
13  minimum concentrations at which 90% of the isolates were inhibited
(1 time)
Medicine
(1 time)
--- 2004 Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
14  minimum inhibitory concentrations for 90% of the drug strains
(1 time)
Medicine
(1 time)
--- 1993 In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
15  minimum inhibitory concentrations of 90% of bacterial growth
(1 time)
Infection
(1 time)
Ddn (1 time)
Mtb (1 time)
2020 Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from Mycobacterium tuberculosis.